Big data unlocks new targets to treat influenza
10 December 2015 | By Victoria White
A team of scientists have tapped into publically available large-scale 'Omics' databases to identify new targets to treat influenza...
List view / Grid view
News
Takeda and Cour in coeliac disease collaboration
10 December 2015 | By Victoria White
The partnership will focus on using nanotechnologies based on Cour’s Tolerizing Immune Modifying nanoParticle (TIMP) platform...
Gene therapy early-stage pipeline looks strong, says GBI Research
9 December 2015 | By Victoria White
The gene therapy pipeline has more than 900 products in development, and the early-stage pipeline looks particularly strong with 76% of products at either the discovery or preclinical stage...
Gene therapy used to extend oestrogen’s protective effects on memory
9 December 2015 | By Victoria White
Researchers at University of Florida have used gene therapy in a rat model to show that the expression of a particular receptor can reinstate lost memory function...
JQ1 prevents and reverses liver fibrosis in mice
9 December 2015 | By Victoria White
The discovery, made by scientists from the Salk Institute, could help the millions of people worldwide affected by liver fibrosis and cirrhosis, caused by alcoholism and diseases like hepatitis...
Tc24 protein could hold the key to fighting Chagas disease
9 December 2015 | By Victoria White
Researchers have identified the molecule, Tc24, that is expressed by Trypanosoma cruzi and may facilitate the parasite's evasion of the host's immune system...
Trial of CAR T-cell therapy in head and neck cancer starts
8 December 2015 | By Victoria White
Doctors are harnessing patients’ own immune systems in a pioneering trial taking place in London in an effort to find a new effective treatment for resistant head and neck cancer...
BioAtla and Pfizer in CAB antibody collaboration
8 December 2015 | By Victoria White
BioAtla and Pfizer will each have a license to the other's respective technology to pursue the development and commercialisation of several CAB-ADC antibodies...
Viking announces new preclinical results for VK5211
8 December 2015 | By Victoria White
VK5211 is an orally available, non-steroidal selective androgen receptor modulator (SARM) designed to selectively stimulate muscle and bone formation with reduced activity in peripheral tissues such as skin and prostate...
Researchers one step closer to designer dopamine neurons
7 December 2015 | By Victoria White
Parkinson’s disease researchers at the University at Buffalo have developed a way to ramp up the conversion of skin cells into dopamine neurons...
Nosopharm joins ENABLE to help combat antibiotic resistance
7 December 2015 | By Victoria White
The €100m ENABLE project aims to identify at least three antibacterial lead molecules with promising antibacterial activity, two antibacterial clinical candidate molecules and to enter at least one compound into preclinical and Phase 1 clinical studies...
Cypralis collaborates with Janssen on cyclophilin inhibitors
7 December 2015 | By Victoria White
The collaboration, facilitated by Johnson & Johnson Innovation, aims to develop new cyclophilin inhibitors for neurodegenerative diseases...
Nordic Nanovector presents preclinical research with betalutin
7 December 2015 | By Victoria White
Betalutin is the first in a new class of Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL)...
UCL researchers discover the recipe for painlessness
4 December 2015 | By Victoria White
The researchers made the discovery using mice modified to carry the same mutation as people born without Nav1.7. Their research revealed that people who lack Nav1.7 also produce higher than normal levels of natural opioid peptides...
ICR identify Brf2 as a potential target for future cancer drugs
4 December 2015 | By Victoria White
ICR scientists have discovered Brf2 acts as a ‘master switch’ within cancer cells that seems to override the normal stress response...